Member of the Scientific Advisory Board
Professor Viktor Umansky has studied tumor related immunosuppression for several decades. His work led him to use adoptive cell therapy and to study the immunosuppressive mechanisms, which limit its activity. He is a global leader in understanding tumor mediated immunosuppression and the models that are used for studying it. He works at the leading European Cancer Center DKFZ in Mannheim and Heidelberg. Dr Umansky has published 103 peer reviewed papers, and many of these were on various aspects of interactions between tumor and immune cells.